Age-Related Macular Degeneration
VIDEO: Anti-VEGF biosimilars may offer cost savings, accessibility for AMD treatment
SEATTLE — In this video, Eleonora M. Lad, MD, PhD, vice chair of ophthalmology clinical research at Duke Health, discusses an update on the use of anti-VEGF biosimilars for the treatment of age-related macular degeneration.
Low-dose aspirin use ‘should not be recommended’ to prevent, treat AMD
In an analysis of more than 3,100 older adults, low-dose aspirin administered for 3 years did not affect the incidence or progression of age-related macular degeneration, according to study results published in JAMA Ophthalmology.
VIDEO: Phase 2 data focus on pan-VEGF blockers, tyrosine kinase inhibitors in AMD
SEATTLE — In this video from the ARVO meeting, Jay Chhablani, MD, discusses data on pan-VEGF blockers and tyrosine kinase inhibitors for age-related macular degeneration.
nAMD and DME Management: Scaling Real-World Heights in Durability
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
VIDEO: AI may assist with detecting progression, conversion of AMD
SEATTLE — In this video from the ARVO meeting, Jay Chhablani, MD, discusses the advancement of AI technology to help predict the progression of age-related macular degeneration and geographic atrophy.
Curbside Consults: A Patient With Treatment-Resistant DME
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Curbside Consults: A Patient With Advanced, Treatment-Naive nAMD
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
VIDEO: Presentation focuses on RPE cells in AMD
SEATTLE — In this video, Eleonora M. Lad, MD, PhD, vice chair of ophthalmology clinical research at Duke Health, discusses a presentation at the ARVO meeting on retinal pigment epithelium cells in age-related macular degeneration.
Q&A: Year-round takeaways from Women’s Eye Health and Safety Month
April was Women’s Eye Health and Safety Month, but raising awareness and educating female patients about conditions that predominantly affect women is something eye care providers should prioritize year-round.
ARVO 2024: Possible link between long COVID, vision changes tops Healio’s written items
As Healio’s coverage of the Association for Research in Vision and Ophthalmology meeting winds down, catch up on this year’s most popular articles.